These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3315195)

  • 61. Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study.
    Jodrell DI; Smith IE
    Cancer Chemother Pharmacol; 1990; 26(1):62-4. PubMed ID: 1691051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer chemotherapy: carboplatin v cisplatin.
    Drug Ther Bull; 1987 Aug; 25(17):67-8. PubMed ID: 3308394
    [No Abstract]   [Full Text] [Related]  

  • 63. Therapeutic potential of ectopic olfactory and taste receptors.
    Lee SJ; Depoortere I; Hatt H
    Nat Rev Drug Discov; 2019 Feb; 18(2):116-138. PubMed ID: 30504792
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of two methods for carboplatin dosing in children with retinoblastoma.
    Allen S; Wilson MW; Watkins A; Billups C; Qaddoumi I; Haik BH; Rodriguez-Galindo C
    Pediatr Blood Cancer; 2010 Jul; 55(1):47-54. PubMed ID: 20486170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The history of ependymoma management.
    Shim KW; Kim DS; Choi JU
    Childs Nerv Syst; 2009 Oct; 25(10):1167-83. PubMed ID: 19458954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug-induced hypomagnesaemia : scope and management.
    Atsmon J; Dolev E
    Drug Saf; 2005; 28(9):763-88. PubMed ID: 16119971
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New drug development for pediatric oncology.
    Weitman S; Carlson L; Pratt CB
    Invest New Drugs; 1996; 14(1):1-10. PubMed ID: 8880388
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical pharmacokinetics of carboplatin in children.
    Riccardi R; Riccardi A; Lasorella A; Di Rocco C; Carelli G; Tornesello A; Servidei T; Iavarone A; Mastrangelo R
    Cancer Chemother Pharmacol; 1994; 33(6):477-83. PubMed ID: 8137457
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modification of the 8 drugs in 1 day regimen: feasibility of substitution of other agents.
    Chan KW; Fryer CJ; Steinbok P
    J Neurooncol; 1990 Oct; 9(2):153-7. PubMed ID: 2262800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
    Gaynon PS; Ettinger LJ; Moel D; Siegel SE; Baum ES; Krivit W; Hammond GD
    Cancer Treat Rep; 1987 Nov; 71(11):1039-42. PubMed ID: 3315195
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.